Aureus Pharma Announces Its Participation in € 118 Million Biointelligence R&D Programme to Promote the Use of Systemic Modelling and Simulation Tools in the Life Science Industry

PARIS--(BUSINESS WIRE)--Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today it’s participation in a EUR118.2 million (USD 160 million) project. The project is the Biointelligence R&D programme designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.